Regular Supplementation With Resveratrol Improves Bone Mineral Density in Postmenopausal Women: A Randomised, Placebo-Controlled Trial

J Bone Miner Res. 2020 Jun 21. doi: 10.1002/jbmr.4115. Online ahead of print.

Abstract

Resveratrol, a naturally-occurring polyphenol in red grapes and berries, can act as a phytoestrogen. It has been shown to improve both systemic and cerebral circulatory functions, possibly through activation of endothelial estrogen receptors. In vitro and in vivo studies in rodent models also indicate a bone-protective role for resveratrol, particularly in ovariectomised rat models that mimic postmenopausal osteoporosis caused by estrogen deficiency. Hypothesising a circulatory benefit of resveratrol in bone tissue, we investigated whether resveratrol supplementation could improve bone health in postmenopausal women. The Resveratrol for Healthy Ageing in Women (RESHAW) trial was a 24-month randomised, double-blind, placebo-controlled, two-period crossover intervention conducted to evaluate the effects of resveratrol (75mg twice daily) on cognition, cerebrovascular function, bone health, cardiometabolic markers and well-being in postmenopausal women. Following 12 months of supplementation with resveratrol versus placebo, there were positive effects on bone density in the lumbar spine (+0.016±0.003 g/cm2 ) and neck of femur (+0.005±0.002 g/cm2 ), which were accompanied by a 7.24% reduction in C-terminal telopeptide type-1 collagen levels, a bone resorption marker, compared to placebo. The increase in bone mineral density in the femoral neck resulted in an improvement in T-score (+0.070±0.018) and a reduction in the 10-year probability of major and hip fracture risk. The magnitude of improvement was higher in women with poor bone health biomarker status. Importantly, the improvement in femoral neck T-score with resveratrol correlated with improvement in perfusion. Our sub-analysis also revealed that the bone-protective benefit of resveratrol was greater in participants who supplemented with vitamin D plus calcium. Regular supplementation with 75mg of resveratrol twice daily has the potential to slow bone loss in the lumbar spine and femoral neck, common fracture sites in postmenopausal women without overt osteoporosis. This article is protected by copyright. All rights reserved.

Keywords: Aging; Clinical Trials; DXA; Menopause; Nutrition.